Researchers report on ctDNA-based detection of residual disease prognostic for resected CRC
by Elana GotkineFor patients with radically resected, stage II to IV colorectal cancer (CRC), circulating tumor (ct)DNA-based detection of molecular residual disease (MRD) in response to adjuvant chem
Updated on: March 05,2024
12

Researchers report on ctDNA-based detection of residual disease prognostic for resected CRC
by Elana GotkineFor patients with radically resected, stage II to IV colorectal cancer (CRC), circulating tumor (ct)DNA-based detection of molecular residual disease (MRD) in response to adjuvant chem
Updated on:March 05,2024
12
